New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
Chopra
I
I
SmithKline Beecham Pharmaceuticals Research & Development, Betchworth, United Kingdom.
Hodgson
J
J
Metcalf
B
B
Poste
G
G
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D001428:Bacterial Vaccines; D003140:Communicable Disease Control / Q000639:trends*; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D004352:Drug Resistance, Microbial / Q000235:genetics / Q000502:physiology; D005798:Genes, Bacterial / Q000187:drug effects; D006801:Humans; D014774:Virulence / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines